HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty Makes Offer For Avon, Smelling “Blood in the Water” – Analyst

This article was originally published in The Rose Sheet

Executive Summary

Coty envisions “an iconic beauty company” to emerge from its proposed acquisition of Avon; however, the direct seller’s management has dismissed the offer as “opportunistic” and not in shareholders’ best interest. Coty is now appealing directly to shareholders, highlighting the firms’ complementary product portfolios and geographical strengths. Meanwhile, Avon seems intent on finding growth and profitability on its own.

You may also be interested in...



Coty Flexes Financial Muscle With Increased Avon Bid, Sets Deadline

Coty ups its offer for Avon, bringing in friends with deep pockets to help finance the deal. The New York-based firm sets a May 14 deadline for Avon to consider its new bid of $24.75 per share.

Avon’s Dismal Q1 Makes Coty Bid More Appealing – Analysts

The first fiscal quarter of 2012 was “unexpectedly weak” for Avon Products, with sales down 2% to $2.6 billion and net income plummeting 82% to $26.5 million, making clear the challenges ahead for the firm and its new CEO. Analysts believe Coty may have a better chance of acquiring the New York-based direct seller in light of the Q1 results.

McCoy Exits J&J For Avon After Gorsky Promotion

Passed over to succeed outgoing CEO William Weldon, top Johnson & Johnson consumer business exec Sheri McCoy exits the firm after 30 years to become Avon’s CEO. While J&J’s consumer business is recovering gradually, Avon faces a hostile takeover bid and is dealing with internal struggles.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018040

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel